Introducing long-acting injectable lenacapavir as HIV pre-exposure prophylaxis: implementation considerations
Introducing long-acting injectable lenacapavir as HIV pre-exposure prophylaxis: implementation considerations Imberss Wed, 11/11/2026 - 14:22 Publication Date Wednesday, November 11, 2026 - 14:22 Asset Type Publication Keywords HIV Treatment HIV Prevention Science and research Guidance report UNAIDS Publication Show in Archive list 1 Generate Landing page 1 Show banner in homepage 0 Document Document 20261111_LEN_Introduction_guide.pdf (649.36 KB) Banner settings Homepage image settings Default video format YouTube Introduction media This guide provides practical guidance for countries considering whether and how to introduce LEN for PrEP as part of their HIV prevention response. It supports context-based decision-making on whether and how to introduce LEN, recognizing that decisions should reflect epidemiological need, health system readiness, PrEP programme maturity, financing, supply, and community priorities. Asset thumbnail Add banner to homepage 0 Mark this asset as speech 0 Include border 1 Show in Homepage News 0
Forfait Gratuit · Plus 29 $ CA ou Pro 99 $ CA/mois


